Xenoestrogens from synthetic or natural origin represent an increasing risk of disrupted endocrine functions including the physiological activity of the hypothalamo-pituitary-gonad axis. Ethinyl estradiol (EE2) is a synthetic estrogen used in contraceptive pills, whereas zearalenone (ZEA) is a natural mycoestrogen found with increasing prevalence in various cereal crops. Both EE2 and ZEA are agonists of estrogen receptor-␣ and accelerate puberty. However, the neuroendocrine mechanisms that are responsible for this effect remain unknown. Immature female Wistar rats were treated with EE2 (10 g/kg), ZEA (10 mg/kg), or vehicle for 10 days starting from postnatal day 18. As a marker of puberty, the vaginal opening was recorded and neuropeptide and related transcription factor mRNA levels were measured by quantitative real time PCR and in situ hybridization histochemistry. Both ZEA and EE2 accelerated the vaginal opening, increased the uterine weight and the number of antral follicles in the ovary, and resulted in the increased central expression of gnrh. These changes occurred in parallel with an earlier increase of kiss1 mRNA in the anteroventral and rostral periventricular hypothalamus and an increased kisspeptin (KP) fiber density and KP-GnRH appositions in the preoptic area. These changes are compatible with a mechanism in which xenoestrogens overstimulate the developmentally unprepared reproductive system, which results in an advanced vaginal opening and an enlargement of the uterus at the periphery. Within the hypothalamus, ZEA and EE2 directly activate anteroventral and periventricular KP neurons to stimulate GnRH mRNA. However, GnRH and gonadotropin release and ovulation are disrupted due to xenoestrogen-mediated inhibitory KP signaling in the arcuate nucleus. (Endocrinology 156: 3996 -4007, 2015) 
structure of ZEA and 17␤-estradiol, ZEA has the capability to bind to the ligand-binding pocket of the estrogen receptor (ER) and stabilize at least one of the functionally active conformations of the receptor's ligand binding domain (5) . ZEA preferentially activates ER␣ and displays partial antagonist activity on ER␤, especially at high concentrations (9, 10) .
Depending on the developmental timing of mycotoxin exposure, ZEA has multiple adverse effects on female reproduction (11) including enlargement of the uterus (7, 8) , persistent anovulatory cycles (12, 13) , decreased fertility, and defective embryonic implantation and development (14) .
It has been repeatedly shown that ZEA administration accelerates the puberty onset in mice (13, 15) and rats (8) but not in gilts (11, 12, 16) .
Sporadic epidemics of precocious puberty in human females were attributed to exposure of anabolic estrogens in animal foods such as ZEA in Italy (17) , Puerto Rico (18, 19) , and Hungary (20) . However, the neuroendocrine mechanism through which estrogenic mycotoxins accelerate puberty onset remains to be elucidated.
Ethinyl estradiol (EE2) is the major estrogenic component of contraceptive pills, which are often taken at peripubertal ages. EE2 is also prescribed to alleviate menopausal symptoms, used as palliative therapy in malignant tumors of breast and prostate cancer, and also applied as steroid substitution to girls with Turner syndrome. Unintended EE2 exposure may also originate from the environment, in which significant amounts of EE2 have been detected due to the urine and feces of women taking the contraceptive pill. An additional load may originate from livestock and aquaculture (21, 22) . EE2 and ZEA are both ER␣ ligands. Previous in vivo studies have shown that EE2 and ZEA elicit similar effects on the timing of puberty, although ZEA has a lower efficacy and a 1000-fold lower potency than EE2 (6, 23) . Increasing evidence indicating that exposure to different estrogenic compounds results in compound-specific effects on morphological, histological, and molecular level (24, 25) led us to study and compare neuroendocrine mechanisms that are responsible for advanced puberty in rats treated with EE2 and ZEA.
Kisspeptin (KP) and its receptor, G protein-coupled receptor 54 (GPR54) (kisspeptin-1 receptor) have been implicated in initiation of puberty and regulation of the hypothalamo-pituitary-gonad (HPG) axis through GnRH synthesis and release (26 -29) . KP is synthesized by two distinct groups of hypothalamic neurons in the anteroventral periventricular (AVPV) and arcuate (ARC) nuclei, respectively (30, 31) . KP is a potent GnRH secretagogue, results in depolarization of GnRH neurons, and advances puberty in mice (28) . By contrast, mutations of the gpr54 gene are associated with impaired sexual maturation in mice and humans (32, 33) . Furthermore, GnRH-specific gpr54 knockout results in delayed puberty onset, abnormal estrus cycles, and infertility (34, 35) .
Most KP neurons express ER␣, which plays a fundamental role in mediation of steroid feedback on the HPG axis (36 -38) . The two KP neuron populations display differential responsiveness to estrogens because kiss1 expression is stimulated by 17␤-estradiol in the AVPV but inhibited in the ARC (39, 40) . Furthermore, studies on mice with conditional knockout of the ER␣ gene from kisspeptin neurons revealed that estrogen-responsive KP cells in the arcuate nucleus restrain the HPG axis and delay puberty onset in juvenile animals, whereas subsequent ERdependent activation of GnRH neurons depends on AVPV KP input, which accelerates gonadal, hormonal, and sexual maturation during puberty (41) . Recent findings suggest that puberty occurs when kiss1 in the ARC is relieved from the suppression mediated by the polycomb group of transcription silencing complexes before puberty (42) . Furthermore, the expression of makorin3 (mkrn3), which encodes a transcriptional suppressor protein with ring finger domain, also declines in the mouse hypothalamus just before puberty (43) .
There is increasing evidence for a correlation between body levels of estrogenic endocrine disruptor compounds and precocious puberty in girls. For instance, urinary bisphenol levels were significantly higher in girls with idiopathic central precocious puberty (44) . Recently the association of phthalate exposure, kisspeptin plasma levels, and precocious puberty has been revealed (45) . We hypothesized that the endocrine disruptor effect of the xenoestrogens ZEA and EE2 is mediated through kisspeptinkisspeptin-1 receptor signaling in the hypothalamus. To address this issue, female prepubertal Wistar rats were exposed to ZEA, (an estrogenic mycotoxin) or EE2, (a prototype of estrogenic disruptor compounds), and the physiological and hormonal responses were analyzed together with changes in kisspeptinergic signaling on GnRH neurons. Both EE2 and ZEA advanced puberty onset in females. This was accompanied by selective increase of kiss1 and gnrh mRNA expression in the anterior hypothalamus, without noticeable changes of kisspeptin signaling in the ARC. These results identify kisspeptin-GPR54 signaling as a central target of the endocrine disruptor effect of EE2 and the ZEA.
Materials and Methods

Animals
Female Wistar rats (n ϭ 40) from the colony bred at the Institute of Experimental Medicine (Budapest, Hungary) were used. Animals were kept at the minimal disease (MD) level of the institute's animal facility under standard conditions (temperature 22°C Ϯ 3°C; relative humidity 30%-70%; lighting 12 h light, 12 h dark cycle; lights on at 7:00 AM). Animals had free access to phytoestrogen-free rodent diet (Harlan Teklad Global Diets) and tap water. Rats were weaned, weighed, and randomly allocated to treatment groups at postnatal day (PND) 18. All procedures were conducted in accordance with the guidelines set by the European Communities Council Directive (86/609 EEC) and approved by the Institutional Animal Care and Use Committee of the Institute of Experimental Medicine (permit numbers PEI/001/35-4/2013 and PEI/ 001/29-4/2013).
Treatment and processing
Rats were treated with EE2 (Sigma; 10 g/kg body weight) or ZEA (Sigma; 10 mg/kg body weight [bw]) for 10 consecutive days, starting at PND 18 according to the protocol used for the immature rat uterotrophic assay developed and validated by the Organisation for Economic Co-operation and Development (protocol number 440, http://www.epa.gov/endo/pubs/ uterotrophic_oecd_guideline.pdf). The dose of the ZEA was based on our previous study (8) , whereas the dose of EE2 was selected in a pilot uterotrophic assay (Supplemental Figure 1 ). EE2 and ZEA were dissolved first in alcohol and then diluted in olive oil at a ratio of 1% ethanol and 99% oil. The vehicle was also prepared with the same ratio. Drugs and vehicle were administered daily by oral gavage (1 mL/kg bw), between 9:00 and 11:00 AM. For each animal, individual doses were calculated daily, after measurement of the body weight. Based on the doseresponse studies, in the main experiment, the following groups were used: 10 g/kg bw EE2 (n ϭ 14), 10 mg/kg bw ZEA (n ϭ 11), and the vehicle oil (control, n ϭ 15). Rats were randomly assigned to treatment groups. Animals were housed in groups of four to five per cage during treatment, and the sequence of the treatments varied day by day. The weight of animals and food and water consumption were measured, and the vaginal opening was examined daily, before gavage.
On PND 28, vaginal smears were taken, and then the rats were killed by decapitation, and trunk blood was collected for hormone measurement. The brain was rapidly removed from the skull, placed into acrylic coronal matrix, and dissected to isolate an AVPV/preoptic area (POA)-enriched region and an ARC-enriched region (see Figure 3) . Viewing from the ventral surface of the brain, a series of three cuts in the coronal plane were made using a sterile razor blade: the first cut was placed 2 mm in front of the optic chiasm, the second one at the apex of the pituitary stalk, and the third one at the rostral margin of the mammillary bodies. This sectioning resulted in two hypothalamic slabs that were placed flat facing to the plane of the second cut. AVPV/POA regions were dissected from the first slab by two sagittal cuts 2 mm from the midline and one horizontal cut just above the third ventricle. ARC-enriched samples were prepared from the second slab by placing two sagittal cuts on either side of the optic tract and a horizontal cut through the middle of the third ventricle. To control the amount of tissue dissected per rats, and thus entering the reverse transcription reaction, hypothalamic tissue samples were weighed. No significant differences in the weight of hypothalamic tissue samples were observed between comparable experimental groups. Dissected tissue samples were immediately frozen on dry ice and stored at Ϫ70°C until assay.
At autopsy, ovaries and the uterus were also removed, weighed, and immersion fixed in 10% buffered formalin. Tissue samples were embedded in paraffin, sectioned (10 m), and stained with hematoxylin-eosin. All microscopic analyses were performed blind to the identification of any group.
RNA isolation and quantitative RT-PCR
For total RNA isolation, hypothalamic blocks were homogenized in 500 L TRI reagent (Ambion). Total RNA was isolated using a total RNA minikit (Geneaid) according to the manufacturer's instructions. To eliminate genomic DNA contamination, deoxyribonuclease I treatment was introduced (1 U per reaction, reaction volume 50 L ribonuclease-free deoxyribonuclease I; Fermentas). Sample quality control and the quantitative analysis were carried out by NanoDrop (Thermo Scientific). cDNA synthesis was performed with the high-capacity cDNA reverse transcription kit (Life Technologies) according to the manufacturer's instructions.
The chosen primer sequences used for the comparative cycle threshold experiments were verified with the Primer Express 3.0 program. The sequences were as follows: gnrh, forward, CCCCAAACT-GATGGCCGCTGTT, reverse, AGGGCGCAACCCATAGGA CCA; kiss1, forward, CACCTGTGGTGAACCCTGAAC, reverse, CAGGCTTGCTCTCTGCATACC; gpr54, forward, TGCAGAC-CGTCACCAATTTC, reverse, TGAAGGGTACGCAGCACAGA; gapdh, forward, ACAGCCGCATCTTCTTGTGC, reverse, GCCT-CACCCCATTTGATGTT; nkb, forward, CTAGCGTGGGA CCGAAGGA, reverse, GCCCATAAGTCCCACAAAGAAGT; dyn, forward, GAATCTGAGCTACTGGGCACTGA, reverse, TTTCTCAAGTCCTCCTCGTTGAA; th, forward, AGTA-CAAGCACGGTGAACCA, reverse, GATGCTGTCCTCTCGG-TAGC; eap1, forward, CTACGAGGTGCGCTTCAAGA, reverse, CTTAGAGACCGCGTCGAAGG; ttf1 (nkx2), forward, CGGGCAAGATGTAGGCTTCTA, reverse, CATGATTCG-GCGTCGGCTTAAC; mkrn3, forward, GCTCCGCAATT CAAGCACAA, reverse, AGCGTGCCTCTAACACTGTC; cux1, forward, GAAAGGCCGAGAACCCTTCA, reverse, TGGTCCTT-GTTGTTGCCCTT; eed, forward, GAACAGCAACCCGGAC-CTCTCG, reverse, TTCCCTTTCCCCAGCTTTTCCTTC; cbx7, forward, GACGCCCATGCTCCCCTCAAGT, reverse, CCTCAC-CCAAGCCCCAAGAAACAC; er␣, forward, CCGCCTTCTA-CAGGTCCAAT, reverse, GAAAGCCTTGCAGCCTTCAC; and er␤, forward, GTTGTGCCAGCCCTGTTACTAGTC, reverse, GGTACACTGATTCGTGGCTGGACAGATATA.
The primers (Invitrogen) were used in a real-time PCR with a Fast EvaGreen quantitative PCR master mix (Biotium) on an ABI StepOnePlus instrument (Applied Biosystems). The gene expression was analyzed using the ABI StepOne 2.1 program (Applied Biosystems). The amplicons were tested by melt curve analysis on an ABI StepOnePlus instrument (Applied Biosystems). Experiments were normalized to gapdh expression.
Perfusion and tissue processing for in situ hybridization histochemistry and immunocytochemistry
Another set of vehicle-, ZEA-, and EE2-treated rats (n ϭ 16) was deeply anesthetized on PND 28 with pentobarbital (100 mg/kg, ip) and perfused through the ascending aorta with saline followed by ice-cold fixative (4% paraformaldehyde in 0.1M Borate buffer [pH 8]). Brains were postfixed in the fixative for 3 hours and then placed in 0.1 M potassium PBS containing 10% sucrose overnight. A series of 30-m frontal sections were cut on a freezing microtome, collected in a cryoprotectant, and stored at Ϫ20°C until processing.
In situ hybridization histochemistry
Antisense complementary RNA (cRNA) probes labeled by 35 S-uridine triphosphate (DuPont NEN) were used throughout. The kisspeptin probe was transcribed from a 411-bp mouse cDNA template (bases 76 -486 of AF472576) subcloned into pGEMTEasy. The plasmid was linearized by Sac1 and used as template for in vitro RNA transcription using T7 RNA polymerase.
The probe for GPR54 in situ hybridization histochemistry was produced in our laboratory using rat hypothalamic cDNA as a template to generate a gpr54-specific PCR fragment. The PCR was carried out using gpr54 forward and T7 gpr54 antisense primers. The amplicon was visualized by gel electrophoresis (1.8% agarose gel, 0.5 ϫ Tris-borate EDTA buffer), and the gpr54-specific PCR product (473 bp) was isolated from the gel (gel/PCR DNA fragment extraction kit; Genaid). This fragment (10 ng) was served as a template to a second PCR to increase the specificity of the gpr54 amplicon. The second PCR was carried out using T7 and gpr54 forward primers, and the PCR product was visualized and isolated as above. Details of the PCRs and primer sequences are described in the Supplemental Methods. The amplicon (50 ng) served as a template for in vitro radionuclide ( 35 S-uridine-triphosphate; DuPont NEN)-labeled cRNA probe synthesis using T7 RNA polymerase. The specificity of the designed primers was verified by Primer Blast software.
Hybridization and autoradiographic procedures were modified following those of Simmons et al (46) . Tissue sections were mounted onto SuperFrost Ultra Plus slides (Menzer-Glazer Braunschweig) postfixed with 4% paraformaldehyde, digested with Proteinase K (10 g/mL in 50 mM Tris [pH 8] and 5 mM EDTA [pH 8] at 37°C for 10 min), acetylated (0.25% acetic anhydride in 0.1 M triethanolamine [pH 8]), and dehydrated. Hybridization mixture (50% formamide, 0.3 M NaCl, 10 mM Tris [pH 8], 2 mM EDTA, 1ϫ Denhardt's, 10% dextran sulfate, 0.5 mg/mL yeast tRNA, and 10 mM dithiothreitol [DTT]) was pipetted onto the slides (100 L, containing probe at 10 7 dpm/ mL) and hybridized overnight at 56°C. Sections were then rinsed in 4ϫ saline sodium citrate [SSC] (1ϫ SSC: 0.15 M NaCl and 15 mM trisodium citrate buffer, [pH 7]), digested with ribonuclease A (20 g/mL in Tris-EDTA buffer with 0.5 M NaCl at 37°C for 30 min), gradually desalted in 2ϫ SSC-1ϫ SSC-0.5ϫ SSC all with 1 mM DTT for 5 minutes each, and washed in 0.1ϫ SSC with 1 mM DTT at 65°C-75°C for 30 minutes and dehydrated in alcohols. Slides were exposed to Phosphoimager image plates for 24 -48 hours and then dipped in nuclear emulsion (NTB Kodak) and exposed for 2-3 weeks, developed in D-19 developer, and lightly counterstained with cresyl violet. Densitometric analysis of the in situ hybridization histochemistry was performed using the advanced Image Data Analyzer (AIDA version 3.1) software on scanned images obtained by the BASReader program (Raytest Isotopenmessegerate GmbH). Anatomical regions of interest were identified using a rat brain atlas. The density measurement was corrected by subtraction of a background value obtained from a neighboring nonhybridized tissue area from the same section.
Double immunofluorescence for GnRH and kisspeptin immunoreactivity
To evaluate changes in KP fiber density and kisspeptinergic inputs to GnRH neurons, double-labeling immunofluorescence was performed. After blocking in 2% normal goat and donkey serum, free-floating sections were incubated in a mixture of guinea pig anti-GnRH (number 1018 Hrabovszky, 1:3000 [47] ) and rabbit anti-KP (number 566, Caraty, 1:10 000 [48] ) overnight at 4°C ( Table 1) . The antigens were then visualized by biotinylated goat antiguinea pig IgG (Vector Labs; dilution 1:500) for 1 hour followed by streptavidin ALEXA 350 (Molecular Probes; 1:500) and donkey antirabbit ALEXA 488 (Molecular Probes; 1:500) for 3 hours. After PBS washing, the sections were mounted onto chrome-alum gelatin-coated slides and coverslipped with ProLong Gold antifade reagent (Life Technologies).
Confocal microscopic analysis
Confocal imaging was performed on Olympus FluoView FV1000 (Olympus) laser-scanning confocal microscope using ϫ100/1.45 oil objective. All image acquisition and quantification was performed by an individual blind to the treatment conditions. Images were consistently collected at, but not past, the threshold of overexposure to standardize analysis parameters across image stacks. KP fiber projections to GnRH neurons were evaluated at the rostral POA by using z-stack imaging. Threedimensional image analysis was carried out by using Imaris software (Bitplane). From each animal, nine GnRH neurons were selected in the double-immunostained (GnRH and KP) material using the following criteria: 1) the cell had definitive GnRH immunoreactivity, 2) the total plane of the soma was visible within the z-stack, 3) had a defined nucleus, and 4) sufficiently separated from other cells to clearly identify kisspeptin fiber appositions. The GnRH neurons were identified by slowly scrolling through the z-plane. To quantify the number of GnRH/KP appositions, we counted the total number of immunoreactive boutons in ap- position to the soma through the complete z axis of each of the nine cells. These appositions were defined by visualizing no visible space between KP-immunoreactive profiles and the GnRH cell membrane. GnRH/KP double-stained hypothalamic sections have been used to quantify KP fiber density in the preoptic area. The region of interest has been selected by revealing GnRH-immunoreactive cells, and the density of KP-immunoreactive fibers were analyzed after thresholding in ImageJ software (National Institutes of Health, Bethesda, Maryland). In this analysis the data represent the area occupied by immunolabeled fibers as a proportion of the total region of interest area but not the specific number of fibers.
Hormone measurement
After decapitation, trunk blood was collected into ice-cold EDTA-containing tubes, centrifuged, and plasma samples were then stored at Ϫ20°C until assay. Plasma hormone levels were measured by enzyme immunoassay (EIA) kits obtained from NovaTec Immunodiagnostica GmBH, according to the manufacturer's instructions. 17-␤-Estradiol EIA kit (catalog number DNOV003; assay range 0 -2000 pg/mL; sensitivity 5 pg/mL; accuracy 96.5% Ϯ 3.1%; intra-and interassay coefficients of variations are 3.2% and 5.4%, respectively). The assay showed less than 0.001% cross-reactivity with ZEA. The lowest detectable concentrations of FSH (catalog number DNOV031) and LH (catalog number DNOV030) EIA kits are 0.6 and 0.5 mIU/mL, respectively). The measured values were transformed to picograms per milliliter in the case of LH and FSH.
Statistical analysis
The results are shown as means Ϯ SEM. Data were assessed for normality and homogeneity of variances by KolgomorovSmirnov tests and then analyzed by a one-way ANOVA (GraphPad Prism) followed by Bonferroni's or Tukey post hoc tests. In case of data showing non-Gaussian distribution, the MannWhitney U test was used. Body weight data were analyzed with a repeated-measure ANOVA, time being the repeated measure. In all cases, differences were considered statistically significant at P Ͻ .05.
Results
Vaginal opening: onset of puberty
Both ZEA and EE2 advanced puberty as measured by the number of rats showing vaginal opening, an external sign of puberty onset. One hundred percent of rats showed a vaginal opening at PND 24 or PND 25 in case of EE2-or ZEA-treated rats, respectively. None of the vehicletreated control animals displayed a vaginal opening before the end of the experiment at PND 28 ( Figure 1A) . Vaginal opening in the naïve group occurred at PND 30 -31 (Supplemental Figure 1 ).
Vaginal smears taken at the end of the experiment (PND 28) revealed that 62.5% of ZEA-treated rats showed proestrous-like, 12.5% estrous-like, and 25% metestrous-like smears. Among the rats treated with EE2 for 10 days, on the basis of vaginal smears, 37.5% were in proestrus, 37.5% in estrus, and 25% in metestrus.
Ten-day ZEA and EE2 treatment resulted in a significant enlargement of the uterus (F [2.26] ϭ 35,10, P Ͻ .0001) compared with controls. The normalized uterus weight of ZEA-or EE2-treated animals were 2.16-fold and 2.34-fold higher, respectively, than those of vehicle-treated rats ( Figure 1B) .
Histological analysis of the hematoxylin-eosin stained ovarian sections revealed a large number of small antral follicles in ZEA-and EE2-treated animals. No corpora lutea were observed in the xenoestrogen-treated rats (Supplemental Figure 2) .
Because the timing of puberty depends on the metabolic resources of the animals, we checked whether xenoestrogen treatment affected body weight. Repeated-measures ANOVA on daily body weight data and one-way ANOVA on cumulative body weight gain data revealed a significant effect of treatment (F [2.37] ϭ 10.58, P ϭ .0002). Bonferroni's post hoc test indicated that EE2-treated premature female rats gained significantly less body weight during the treatment period (PND 18 -28) than vehicle-or ZEAtreated animals ( Figure 2, A and B) . Daily and cumulative food and water intake of the three groups were not significantly different (Supplemental Figure 3) .
Xenoestrogens increase gnrh expression in the hypothalamus
Next, we investigated the effect of xenoestrogens on gnrh mRNA levels in the hypothalamus. gnrh expression was significantly increased after EE2 or ZEA treatment as measured by a quantitative PCR from AVPV/POA-enriched brain tissues (P ϭ .0012 for both xenoestrogens by a Mann-Whitney U nonparametric test) relative to vehicle-treated rats. ZEA and EE2 treatments resulted in 2.52-fold and 3.65-fold increases, respectively ( Figure 3B ). 
ZEA and EE2 differentially affect kiss1 and gpr54 mRNA levels in the hypothalamus
Aperipubertalincreaseofgnrhisattributable,atleastinpart, to estrogen-sensitive inputs to the GnRH neurons. Among these,kisspeptinergicinnervationplaysapivotalroleinpubertal timing. Because kiss1 expression is regulated reciprocally by estrogen in the AVPV/rostral periventricular (PeV) and ARC regions in the rodent brain, kiss1 and kisspeptin receptor gpr54 mRNA levels were measured in these brain areas separately. Both ZEA and EE2 treatment resulted in a significant increase in kiss1 expression in the AVPV/PeV (ZEA: 2.83-fold increase; EE2: 2.82-fold increase), whereas in the ARC region, significant alterations were not observed ( Figure 3, C and D) . The expression of gpr54 increased significantly only in the ARC (ZEA: 1.68-fold increase; EE2: 1.89-fold increase, Figure 3 , E and F).
Within the arcuate block, the relative quantity of neurokinin B (nkb) mRNA levels decreased in ZEA-and EE2-treated rats (F [2.11] ϭ 6.71; P ϭ .013). However, the expression of dynorphin (dyn) did not differ in xenoestrogentreated animals compared with the vehicle-treated controls ( F [2.12] ϭ 0.17; P ϭ .84) (Figure 4) .
No changes were detected in the hypothalamic mRNA levels of ERs er␣ (F [2.10] ϭ 2.77; P ϭ .11) or er␤ (F [2. 10] ϭ 1.27; P ϭ .30 not shown).
Ring-finger transcription factor makorin 3 (mkrn3) has been implicated in sexual development as abreakofpuberty (49) .Mkrn3mRNAwaselevatedexclusively in the AVPV/PeV after the EE2 treatment (Supplemental Figure  4) . A small increase in the mRNA level of eed was also detected in the anterior hypothalamic block (Supplemental Figure 4) . The relative quantities of cbx7, cux1, eap1, and ttf1 transcription factor mRNA remained unaltered in ZEA-and EE2-treated animals compared with vehicle controls (Supplemental Figures 5 and 6 ).
In situ hybridization histochemical localization of kiss1 and gpr54 mRNA
In vehicle-treated female rats, we found kiss1 in situ hybridization signals exclusively over the neurons in the press.endocrine.org/journal/endoAVPV, the rostral PeV, and the ARC nuclei. In response to ZEA or EE2 administration, increased kiss1 mRNA expression was revealed in the AVPV/PeV ( Figure 5 ), without detectable changes in the ARC. Extrahypothalamic expression of kiss1 was not detected after the xenoestrogen treatment. 35 S-uridine-triphosphate-labeled riboprobes corresponding to gpr54 mRNA revealed a specific pattern of KP receptor expression in the rat brain. In vehicle-treated animals, intense hybridization signals were detected in the cortical layers as well as in the CA1-4 areas and the dentate gyrus of the hippocampal formation. Strong labeling corresponding to gpr54 mRNA has been revealed in the lateral habenula, in the subfornical organ, bed nucleus of stria terminalis, and the mammillary region. Within the hypothalamus, the POA, suprachiasmatic, supraoptic, caudal paraventricular, ventromedial, and ARC nuclei were moderately labeled. In response to ZEA and EE2, there was a selective increase in the intensity of the hybridization signal in the medial basal hypothalamus (Figure 5) . The strength and distribution of the hybridization signal at the extrahypothalamic areas also remained unchanged after ZEA and EE2 treatment (data not shown).
Endocrine disruptors increase KP fiber density in the preoptic area and the number of KP appositions onto GnRH neurons
Analysis of immunofluorescent material revealed an increased density of KP-immunoreactive fibers in the preoptic region of ZEA-and EE2-treated animals. One-way ANOVA revealed a significant treatment effect (F [2.6] ϭ 5.65, P ϭ .042). Treatment with the endocrine disruptors resulted in 5-fold and 8-fold increases in the KP fiber density in the case of ZEA and EE2, respectively (F [2.15] ϭ 12.06, P ϭ .0008) (Figure 6 ). Furthermore, using double-labeled immunfluorescence, we revealed KP fibers in close apposition to GnRH neurons in the POA. Specifically, the number of KP appositions on GnRH neurons was significantly increased in the EE2-and ZEA-treated animals (F [2.24] ϭ 9.5; P ϭ .0009) (Figure 6 ).
Effect of ZEA on plasma hormone levels
Plasma LH (F [2.11] ϭ 0.90, P ϭ .42) and FSH (F [2.9] ϭ 0.14, P ϭ .87) concentrations did not change significantly after ZEA or EE2 treatment. EE2, but not ZEA, administration significantly reduced the 17␤-estradiol concentration (F [2.12] ϭ 8.01, P ϭ .006) by the end of the 10-day administration period (Figure 7 ).
Discussion
This study shows that administration of two xenoestrogens, the synthetic estrogen derivative EE2 and the nonsteroidal mycoestrogen ZEA, to sexually immature prepubertal female rats advances puberty, which is paralleled by increases in KP signaling to GnRH neurons and increased gnrh expression. The effect of xenoestrogens on KP neurons is site and gene specific because 10 days of ZEA or EE2 administration elevated kiss1 mRNA levels exclusively in the AVPV/PeV but not in the ARC region.
Previous experiments on laboratory rodents and domestic animals, and studies on mycotoxin exposed humans, have established the endocrine-disruptive and puberty-accelerating effects of ZEA. In this study on rats, we have used the time of vaginal opening as the first phenotypic marker of puberty onset in rodents, although the central and peripheral mechanisms that contribute to this process are not fully understood. It should also be noted that accelerated vaginal opening does not necessarily indicate onset of normal estrous cycles, and there are examples when the 
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timing of vaginal opening and maturation of central neuroendocrine circuits are not correlated (50, 51) . It is very likely that in addition to their central effects, xenoestrogens may directly stimulate peripheral estrogen-sensitive tissues such as the vagina and uterus to produce morphological and histological changes seen in puberty. We found ZEA-and EE2-induced accelerated vaginal opening to be accompanied by significant increases in gnrh mRNA levels in the anterior hypothalamus. Indeed, stimulation of gnrh gene expression is the ratelimiting factor for the onset of puberty (52), although GnRH neurons are not directly responsive to the positive feedforward effects of estrogens that initiate sexual maturation.
Among the neurotransmitters and neuropeptides that regulate GnRH neurons, KPs and other RFamide-related peptides have been implicated in the mediation of estrogen effects and the progression of puberty. Most KP neurons express ER␣ (41, 48) , and kisspeptinergic fibers have been identified to form synaptic contacts with GnRH neurons (53, 54) that possess GPR54, the KP receptor (29, 55) . Furthermore, KP alters the press.endocrine.org/journal/endo 4003 electrophysiology and activation of GnRH neurons (56, 57) . Sex steroids play a prominent role in driving morphological and functional plasticity of the hypothalamic KP system during puberty (40) . During pubertal maturation, there is a significant increase in KP content and the number of contacts between KP and GnRH neurons (58) . ZEA and EE2 elevated the KP fiber density in the anterior hypothalamus, and the number of KP appositions on GnRH neurons was also increased. Although these contacts have not been confirmed by high-resolution microscopy, the light microscopic morphological rearrangements seen after ZEA and EE2 administration are compatible with increased kisspeptinergic drive to GnRH neurons similar to that seen in normal puberty. During normal puberty, there is a shift from the inhibition to stimulation of GnRH neurons via changes in kisspeptinergic signaling. Based on our present data, ZEA and EE2 stimulate GnRH expression via the activation of the AVPV KP drive. However, GnRH release and subsequent gonadotropin release is blocked by an excess of xenoestrogens. One concern might be the specificity of the KP antibody because many of these antibodies cross-react with other members of RFamide-related peptides, RFRPs. Indeed, there are some mismatches between staining patterns generated by two N-terminal antibodies vs the C-terminalspecific antibody (AC566) used in this experiment (Table  1) . However, KP staining remains after preabsorption with the RFRP antibody, whereas it is completely absent in KP knockout mice (59) .
In addition to morphological changes in kisspeptinergic neurocircuits, we have revealed a significant increase in the kiss1 mRNA levels in the hypothalamus after 10 days' administration of endocrine disruptor compounds. Of note, our data revealed site-specific effects of ZEA and EE2 on kisspeptin expression in the AVPV region, which is compatible with the positive feedback effect of estrogens on KP synthesis in this region. An estrogen-mediated gradual increase of KP peptide expression is necessary for puberty onset (60) . It is intriguing that ZEA or EE2 treatment in the prepubertal period had no effect on kiss1 mRNA levels in the arcuate nucleus.
The molecular mechanisms through which estrogenic compounds produce opposite effects on kiss1 transcription at AVPV and ARC remain to be fully explored. Previous studies indicated that estrogen-induced kiss1 expression in the AVPV requires an ER-DNA interaction, whereas the inhibition of KP mRNA levels in the ARC occurs through a nongenomic action or other ERE-independent effects of estrogens. ZEA and EE2 might also increase kiss1 transcription in the AVPV through the classical nuclear estrogen-response element-mediated pathway. In support of this, it has been shown in vitro that ZEA had strong estrogenic effects due to its ability to activate both activation function-1 and activation function-2 (AF-1 and AF-2) acidic domain functions (61) .
As yet, the potential contribution of such differential signaling to the developmental actions of xenoestrogens has not been studied in detail and will merit specific investigation. This differential regulatory pathway may explain the different sensitivity of KP neurons to the normal organizing effects of sex steroids in different hypothalamic nuclei; AVPV neurons display a higher degree of sexual dimorphism than ARC neurons in rodents (30) . In addition, recognition of this divergent regulatory mechanism may help to define the different modes of actions of estrogens and xenoestrogens on KP neurons, which may involve nonclassical ER pathways as well as ER-independent mechanisms, in line with emerging data in other target tissues of endocrine disruptors. It should be added, however, that long-term treatment with ZEA or EE2 did not alter ER␣/ER␤ mRNA levels in the hypothalamus. Another possibility for the differential effect of these xenoestrogens on KP neuron populations would be differential recruitment of steroid receptor coactivators or corepressors in the AVPV vs ARC.
Two critical periods have been identified during the sexual development in which rodents are specifically vulnerable to endogenous and exogenous estrogenic compounds including endocrine disruptors: the perinatal and the peripubertal age (62) . Prenatal, neonatal, or early postnatal exposure of natural, synthetic, or phyto/xenoestrogens can have both feminizing and defeminizing effects on the developing neural mechanisms that control sexual behavior (63) . KP neurons are especially sensitive to both the early organizing and the acute regulatory actions of estrogens (62) . These organizational steroid actions cause reduced kisspeptin transcription and cell numbers in the AVPV and KP inputs to GnRH neurons in adults. For instance, female rats exposed in utero (gestational d 6 -21) to EE2 were heavier and had delayed vaginal opening, aberrant estrous cyclicity, and masculinized behavior (64) . By contrast, upon exposure during the prepubertal, activation phase, estrogens stimulate kiss1 mRNA and KP fiber density in the hypothalamus and drive GnRH neurons. Here we have provided evidence that the estrogenic mycotoxin ZEA and EE2 administered to female rats at prepubertal ages increases kiss1 expression, enhances the density of KP-immunoreactive fibers in the anterior hypothalamus, and increases appositions between KP-containing profiles and GnRH neurons similarly to changes seen during puberty. These transcriptional changes and morphological rearrangements might be responsible for the enhanced gnrh mRNA transcription and puberty ac-celeration. Our data on the prepubertal effects of EE2 are in contrast with data obtained by Overgaard et al (65) , who found a minor if any effect of perinatal EE2 exposure on hypothalamic kisspeptin expression or puberty onset. From birth to puberty, there is a continuous increase in the number of KP-neurons in the AVPV region (58) , and KP action through GPR54 on GnRH neurons are essential for triggering HPG activity. Our present study confirmed gpr54 expression in the hypothalamus. However, mRNA levels after ZEA and EE2 treatment did not change in the preoptic region, whereas it increased in the ARC.
The timing of puberty onset is genetically encoded, epigenetically modified, influenced by stimulatory and restraining factors, and is very sensitive to metabolic and environmental cues. Ring finger transcription factor makorin 3 (MKRN 3) has recently been identified as a major developmental restraining factor of the GnRH pulse generator (43, 66) . In mice, expression of mkrn3 mRNA in the ARC is highest at PND 10 -12 and its gradual decline correlates with the increase of Kiss1 and Tac2 at puberty onset (43) . Two genes (eed and cbx7) of the Polycomb group of the transcriptional silencing complex (67) have also been recently implicated in the inhibitory control of hypothalamic kiss1 expression and puberty (42) . Because neither mkrn3 nor eed and cbx7 mRNA levels decrease in response to xenoestrogens, it is likely that EE2 and ZEA advance puberty by stimulating propuberty factors rather than by inhibiting puberty restraining mechanisms.
Puberty timing depends on the metabolic status, which is conferred by hormonal inputs (such as leptin) that signal the energy supplies of the body (68, 69) . It is not likely, however, that ZEA and EE2 significantly affect this pathway because these compounds did not result in overt increase of white fat depots. By contrast, EE2 treatment significantly reduced body weight gain, similar to that observed in ovariectomized rodents after estrogen treatment (70) .
One other confounding factor would be the stress associated with the oral gavage, which has recently been show to alter organization of the ER␣ circuit in the limbic system (71) and might interact with the effects of EE2 or ZEA. However, stress in general-, and stress-induced CRH in particular, delay, rather than accelerate, puberty, as seen in xenoestrogen-treated rats.
Exposure to other endocrine disruptors, such as bisphenol A, genistein, diethylstilbestrol, and dichlorodiphenyl-trichloroethane (DDT) also affect the timing of the vaginal opening, depending on the critical age window (for review see reference 72). Furthermore, some estrogenic endocrine disruptor compounds alter HPG regulation through the kisspeptinergic system. For instance, it has been very recently shown that the acute administration of bisphenol A at proestrus to adult female mice enhances positive estrogenic action and results in an increase of KP activity and gnrh expression (73) . By contrast, in testing of EE2 and an extensive array of pesticides and their combination throughout gestation and lactation, Overgaard et al (65) did not find a significant effect on kiss1 expression.
The xenoestrogen doses used in our experiments have relevance for human exposure. The dose of EE2 corresponds to a daily intake of contraceptive pills taken by adolescent girls for birth control or for treatment of hypogonadism.
The risk of ZEA exposure is increasing: according to a recent analysis, 93%-96% of cereal samples have been contaminated by ZEA in northern Europe (74) . The levels vary by country and by year, but so far, the highest ZEA concentration, 49 mg/kg, was found in a wheat sample from Australia (75) . In a retrospective analysis of girls involved in a school epidemic of premature thelarche in Northern Italy, elevated serum zearalenone/zeranol concentrations were detected (23) .
It should also be noted, however, that our data have a number of limitations in comparison with human exposure. We have used relatively high doses of xenoestrogens and gave them for a limited time at a postnatal/peripubertal age. By contrast, the population is exposed to several compounds at low levels but sometimes for much more prolonged (even life-long) time periods. Furthermore, it is increasingly recognized that the effect of xenoestrogens might be additive with other endocrine disruptive compounds. These complex interactions warrant further studies.
In summary, our present data show that exposure of peripubertal rats to the structurally different xenoestrogens EE2 and ZEA advances puberty onset, very likely by increasing/amplifying the kisspeptinergic drive to GnRH neurons. Because of the high probability of exposure to xenoestrogens, one might be aware of the possible endocrine disruptive effects of these compounds especially in the peripubertal life period.
